The drug could change the course of the AIDS epidemic. But the Trump administration has gutted the programs that might have paid for it in low-income countries.

A new panel of U.S. vaccine advisers appointed by Health Secretary Robert F. Kennedy Jr. will vote on flu shots that contain ...

Dr. Stephana Julia Moss, an investigator at the Canadian Center for Vaccinology (CCfV), Dalhousie University, has been ...

Investing.com -- Shares of AstraZeneca (ST: AZN) and GlaxoSmithKline (LON: GSK) fell Tuesday after former U.S. President ...

What if you could actually see where a drug travels in the body down to the cellular level. Find out how mass spectrometry ...

The global IPV vaccines market is estimated to be valued at USD 199.9 Mn in 2025 and expected to reach at USD 358.5 Mn by 2032 With a CAGR of 8.7% during the forecast period (2025-2032). Coherent ...

A talk with study author on a new combination of acimtamig and an allogeneic natural killer cell product that shows safety ...

Dozens of states are suing to block 23andMe's sale of personal genetic data, citing concerns over customer consent and ...

Volunteers from GSK helped to paint the garden furniture and fences at Elmhurst to improve the experience for residents at ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

GlaxoSmithKline Pharmaceuticals shares reached an all-time high during today's session, hitting Rs 3,176.60 on the NSE. The stock is currently trading at Rs 3,163.50, marking a 1.45% increase.

Based on these findings, mepolizumab is newly approved by the US Food and Drug Administration for the treatment of COPD according to manufacturer GlaxoSmithKline. “This decision is good news for ...